
SKB BIO plans to implement the H-share full circulation plan
SKB BIO-B (06990.HK) announced the proposal to implement the H-share full circulation plan, involving 3.572 million domestic shares and 4.6421 million unlisted foreign shares, and has submitted the relevant filing application to the China Securities Regulatory Commission
